Intragraft platelet-derived growth factor-α and transforming growth factor-β1 during the development of accelerated graft vascular disease after clinical heart transplantation
- 1 December 1999
- journal article
- research article
- Published by Elsevier in Transplant Immunology
- Vol. 7 (4) , 201-205
- https://doi.org/10.1016/s0966-3274(99)80003-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The registry of the international society for heart and lung transplantation: sixteenth official report—1999The Journal of Heart and Lung Transplantation, 1999
- Early inflammatory events associated with chronic allograft rejectionCurrent Opinion in Organ Transplantation, 1999
- Risk factors in chronic rejectionCurrent Opinion in Organ Transplantation, 1999
- Transforming growth factor-beta (TGF-B) and allograft vasculopathy following heart transplantationThe Journal of Heart and Lung Transplantation, 1999
- Intragraft cytokine gene expression: implications for clinical transplantationTransplant International, 1998
- Association between the degree of platelet-derived growth factor-A chain mRNA expression and coronary arteriosclerosis in the transplanted heartHeart and Vessels, 1998
- DONOR-SPECIFIC CYTOKINE PRODUCTION BY GRAFT-INFILTRATING LYMPHOCYTES INDUCES AND MAINTAINS GRAFT VASCULAR DISEASE IN HUMAN CARDIAC ALLOGRAFTS1Transplantation, 1997
- Immunohistochemical analysis of platelet-derived growth factor and basic fibroblast growth factor in cardiac biopsy and autopsy specimens of heart transplant patientsThe American Journal of Cardiology, 1996
- Induction of acidic fibroblast growth factor and full-length platelet-derived growth factor expression in human cardiac allografts. Analysis by PCR, in situ hybridization, and immunohistochemistry.Circulation, 1994
- Chronic Rejection in Experimental Cardiac Transplantation: Studies in the Lewis‐F344 ModelImmunological Reviews, 1993